Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ACB · against 596 other Healthcare companies listed in US-listed
Ranked #248 of 597 · scores higher than 59% of peers · safety percentile 59
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)44 peers with a safety percentile of 50–59, including ACB · Click a bar to see the companies
A mix: stronger debt / equity and current ratio, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ACB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.04× | 0.23× | 73% | 33% | |
| BetaLower is better · 556 reported | 1.42 | 0.95 | 26% | 33% | |
| Current ratioHigher is better · 600 reported | 5.36× | 3.91× | 61% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 244 | 16.8B USD | 59 | 75 | |
| 245 | 3.5B USD | 59 | 75 | |
| 246 | 3.2B USD | 59 | 65 | |
| 247 | 32.8B USD | 59 | 69 | |
| 248 | 327M USD | 59 | 40 | |
| 249 | 302M USD | 59 | 42 | |
| 250 | 660M USD | 58 | 43 | |
| 251 | 23M USD | 58 | ||
| 252 | 775M USD | 58 | 31 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score